These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25247380)

  • 41. Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits.
    Parrish JP; Hughes TV; Hwang I; Boger DL
    J Am Chem Soc; 2004 Jan; 126(1):80-1. PubMed ID: 14709069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catalytic asymmetric diazoacetate cyclopropanation of 1-tosyl-3-vinylindoles. A route to conformationally restricted homotryptamines.
    Marcin LR; Denhart DJ; Mattson RJ
    Org Lett; 2005 Jun; 7(13):2651-4. PubMed ID: 15957913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxic selectivity and solubility--investigating the properties of A-ring substituted nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-ones (nitroCBIs) as hypoxia-activated prodrugs for antitumor therapy.
    Tercel M; Yang S; Atwell GJ; Smith E; Gu Y; Anderson RF; Denny WA; Wilson WR; Pruijn FB
    Bioorg Med Chem; 2010 Jul; 18(14):4997-5006. PubMed ID: 20580559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CC-1065/duocarmycin and bleomycin A2 hybrid agents: lack of enhancement of DNA alkylation by attachment to noncomplementary DNA binding subunits.
    Boger DL; Han N
    Bioorg Med Chem; 1997 Feb; 5(2):233-43. PubMed ID: 9061188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photoactivatable prodrugs of highly potent duocarmycin analogues for a selective cancer therapy.
    Tietze LF; Müller M; Duefert SC; Schmuck K; Schuberth I
    Chemistry; 2013 Jan; 19(5):1726-31. PubMed ID: 23225610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of the first spacer containing prodrug of a duocarmycin analogue and determination of its biological activity.
    Schuster HJ; Krewer B; von Hof JM; Schmuck K; Schuberth I; Alves F; Tietze LF
    Org Biomol Chem; 2010 Apr; 8(8):1833-42. PubMed ID: 20449487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diastereoselective Dieckmann condensation suitable for introduction of the duocarmycin A C6 center: development of a divergent strategy for the total synthesis of duocarmycins A and SA.
    Boger DL; Nishi T
    Bioorg Med Chem; 1995 Jan; 3(1):67-77. PubMed ID: 8612048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highly selective glycosylated prodrugs of cytostatic CC-1065 analogues for antibody-directed enzyme tumor therapy.
    Tietze LF; Herzig T; Fecher A; Haunert F; Schuberth I
    Chembiochem; 2001 Oct; 2(10):758-65. PubMed ID: 11948858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel Class of CC-1065 and Duocarmycin Analogues Subject to Mitomycin-Related Reductive Activation.
    Boger DL; Garbaccio RM
    J Org Chem; 1999 Oct; 64(22):8350-8362. PubMed ID: 11674758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Organocatalytic Michael-alkylation cascade: the enantioselective nitrocyclopropanation of oxindoles.
    Pesciaioli F; Righi P; Mazzanti A; Bartoli G; Bencivenni G
    Chemistry; 2011 Mar; 17(10):2842-5. PubMed ID: 21308819
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies toward the duocarmycin prodrugs for the antibody prodrug therapy approach.
    Li LS; Sinha SC
    Tetrahedron Lett; 2009 Jun; 50(24):2933-2935. PubMed ID: 20160897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological evaluation of prodrugs based on the natural antibiotic duocarmycin for use in ADEPT and PMT.
    Tietze LF; Schmuck K; Schuster HJ; Müller M; Schuberth I
    Chemistry; 2011 Feb; 17(6):1922-9. PubMed ID: 21274943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer.
    Tichenor MS; Trzupek JD; Kastrinsky DB; Shiga F; Hwang I; Boger DL
    J Am Chem Soc; 2006 Dec; 128(49):15683-96. PubMed ID: 17147378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platinum-catalyzed intramolecular alkylation of indoles with unactivated olefins.
    Liu C; Han X; Wang X; Widenhoefer RA
    J Am Chem Soc; 2004 Mar; 126(12):3700-1. PubMed ID: 15038708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores.
    Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA
    J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA sequence selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145.
    Kiakos K; Sato A; Asao T; McHugh PJ; Lee M; Hartley JA
    Mol Cancer Ther; 2007 Oct; 6(10):2708-18. PubMed ID: 17938264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and antitumor activity of water-soluble duocarmycin B1 prodrugs.
    Asai A; Nagamura S; Kobayashi E; Gomi K; Saito H
    Bioorg Med Chem Lett; 1999 Oct; 9(20):2995-8. PubMed ID: 10571162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective treatment of cancer: synthesis, biological evaluation and structural elucidation of novel analogues of the antibiotic CC-1065 and the duocarmycins.
    Tietze LF; Major F; Schuberth I; Spiegl DA; Krewer B; Maksimenka K; Bringmann G; Magull J
    Chemistry; 2007; 13(16):4396-409. PubMed ID: 17455190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.
    Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M
    J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Duocarmycin-based prodrugs for cancer prodrug monotherapy.
    Tietze LF; Schuster HJ; Schmuck K; Schuberth I; Alves F
    Bioorg Med Chem; 2008 Jun; 16(12):6312-8. PubMed ID: 18524605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.